Cann Group Company Top Insiders
| CNGGF Stock | USD 0.01 0.00 0.00% |
Cann Group employs about 12 people. The company is managed by 5 executives with a total tenure of roughly 28 years, averaging almost 5.0 years of service per executive, having 2.4 employees per reported executive. Examination of Cann Group's management performance can provide insight into the company performance.
| Geoff Aldred Insider Chief Officer |
| Steven Notaro Executive Legal and Regulatory Affairs Officer |
Cann |
Cann Group Management Team Effectiveness
The company has return on total asset (ROA) of (0.1255) % which means that it has lost $0.1255 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2995) %, meaning that it generated substantial loss on money invested by shareholders. Cann Group's management efficiency ratios could be used to measure how well Cann Group manages its routine affairs as well as how well it operates its assets and liabilities.Cann Group holds a total of 388.52 Million outstanding shares. Cann Group Limited shows 13.05 percent of its outstanding shares held by insiders and 0.044 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Cann Group in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cann Group, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Cann Group Workforce Comparison
Cann Group Limited is rated second in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 269. Cann Group holds roughly 12.0 in number of employees claiming about 4% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (2.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.16. Cann Group Limited Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cann Group Limited Price Series Summation is a cross summation of Cann Group price series and its benchmark/peer.
Cann Group Notable Stakeholders
A Cann Group stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cann Group often face trade-offs trying to please all of them. Cann Group's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cann Group's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Geoff Aldred | Chief Officer | Profile | |
| Steven Notaro | Legal and Regulatory Affairs Officer | Profile | |
| Clive Fanning | Head Relations | Profile | |
| Shane Duncan | Chief Officer | Profile | |
| MBA MBA | Chief Officer | Profile |
About Cann Group Management Performance
The success or failure of an entity such as Cann Group Limited often depends on how effective the management is. Cann Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cann management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cann management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. The company was founded in 2014 and is based in Port Melbourne, Australia. Cann operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Cann Group Workforce Analysis
Traditionally, organizations such as Cann Group use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cann Group within its industry.Cann Group Manpower Efficiency
Return on Cann Group Manpower
| Revenue Per Employee | 534.2K | |
| Revenue Per Executive | 1.3M | |
| Net Loss Per Employee | 2.2M | |
| Net Loss Per Executive | 5.3M |
Complementary Tools for Cann Pink Sheet analysis
When running Cann Group's price analysis, check to measure Cann Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cann Group is operating at the current time. Most of Cann Group's value examination focuses on studying past and present price action to predict the probability of Cann Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cann Group's price. Additionally, you may evaluate how the addition of Cann Group to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |